Previous Hold Today ACST ranks #2030 as HOLD CANDIDATE. Next Hold
Today ACST ranks #2030 as HOLD CANDIDATE.

ACST stock Acasti Pharma

ACST stock
Acasti Pharma

23 January 2019
Change -2.73%
Chart period: 2018-10-24 - 2019-01-23




Request Prediction

Acasti Pharma Stock Analysis

Technical stock analysis for 23 January 2019

Hold candidate since 2019-01-15 Loss -0.93%
Shorts n/a
Cash n/a
Loans n/a
Beta 1.11
ROA -223.65

Acasti Pharma fell by -2.73% in the last day from $1.10 to $1.07 and has now fallen 3 days in a row. The price has risen in 6 of the last 10 days and is up by 16.3% over the past 2 weeks. Volume has increased in the last day by 18 839 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 187 093 shares bought and sold for approximately $200 190.00.

Close price at the end of the last trading day (Wednesday, 23rd Jan 2019) of the ACST stock was $1.07. This is 2.73% less than the trading day before Tuesday, 22nd Jan 2019.

During day the stock fluctuated 4.76% from a day low at $1.05 to a day high of $1.10.

30 day high of the ACST stock price was $1.15 and low was $0.66.
90 day high was $1.15 and low was $0.60.
52 week high for the Acasti Pharma - $1.80 and low - $0.43.


Acasti Pharma lies in the upper part of a very wide and weak rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $1.16 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 5.64% during the next 3 months and, with 90% probability hold a price between $0.70 and $1.22 at the end of this period.

Click here for today's Top 5 Trending Companies


There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Monday January 14, 2019, which indicates further falls until a new bottom pivot has been found. Acasti Pharma gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". Acasti Pharma holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $1.10. On a fall, the stock will find some support from the long-term average at approximately $0.84. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 69 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Acasti Pharma finds support from accumulated volume at $1.05.

Support: $1.05 Price: $1.07 Resistance: $1.08


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.05 between high and low, or 4.76%. For the last week, the stock has had a daily average volatility of 5.15%.

Our recommended stoploss: $1.00 (-6.61%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 6 days ago.)

Overall risk:

Very Low Low Medium High Very High


Acasti Pharma holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.

Previous Hold Today ACST ranks #2030 as HOLD CANDIDATE. Next Hold
Today ACST ranks #2030 as HOLD CANDIDATE.